Retrospective Study
Copyright ©The Author(s) 2024.
World J Radiol. Aug 28, 2024; 16(8): 337-347
Published online Aug 28, 2024. doi: 10.4329/wjr.v16.i8.337
Table 2 Clinical presentation
Case
Primary disease
Surgery
Period: Surgery to ABF
Complication
Period ABF to complication
Treatment
Outcome
Observation period
F: 73 years Dissection Marfan syndromeReplacement + TEVAR5 yearsNoNoNoAlive5 months
F: 74 yearsAneurysmReplacement TEVAR (10 years after replacement)10 years (1 year)Graft infection hemoptysis2 yearsDrainageDied hemoptysis6 years
M: 67 yearsAortic coarctation AneurysmReplacement26 yearsGraft infection hemoptysisSimultaneousConservativeAlive2 years
M: 73 yearsInfected aneurysmTEVAR1 yearGraft infectionSimultaneousConservativeDied sepsis1 year
M: 57 yearsAneurysmReplacement TEVAR (14 years later from replacement)16 years (3 years)Graft infection hemoptysis7 years    Replacement TEVARAlive18 years
M: 83 yearsAneurysmReplacement23 yearsNoNoNoLost to follow-up7 years